Neutral lipid accumulation in hepatocytes and in the intima of coronary arteries is the first step toward the development of FLD and coronary atherosclerosis, respectively. In both complex disorders, multiple factors confer susceptibility to disease progression with inflammation and fibrosis. HSD17B13 expression is one such susceptibility factor for FLD.